Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival
Top Cited Papers
- 4 January 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 4 (1), e2021869
- https://doi.org/10.1001/jamanetworkopen.2020.21869
Abstract
Renal cell carcinomas (RCC) comprise a heterogeneous group of malignant neoplasms arising from the nephron. With more than a dozen recognized histologic variants of renal cell tumors,1 RCCs may vary widely in their genetic, pathologic, and clinical characteristics. The 3 most common histologic variants of RCC include clear cell RCC (ccRCC), papillary RCC (pRCC), and chromophobe RCC (chrRCC), representing 75% to 85%, 10% to 15% and 5% to 10% of all kidney cancers, respectively.2,3 Comprehensive molecular and genetic analyses conducted through The Cancer Genome Atlas (TCGA) program have demonstrated that these subtypes of RCC are biologically distinct.4-6 Expectedly, the clinical behavior of RCC subtypes is similarly heterogeneous, which is likely a result of the differences in underlying disease biology between histologic variants.7-11Keywords
This publication has 34 references indexed in Scilit:
- The Somatic Genomic Landscape of Chromophobe Renal Cell CarcinomaCancer Cell, 2014
- The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal NeoplasiaThe American Journal of Surgical Pathology, 2013
- Comprehensive molecular characterization of clear cell renal cell carcinomaNature, 2013
- Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell CarcinomaJournal of Clinical Oncology, 2013
- Distribution of metastatic sites in renal cell carcinoma: a population-based analysisAnnals of Oncology, 2011
- Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinibAnnals of Oncology, 2011
- Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell CarcinomaJournal of Urology, 2010
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter StudyJournal of Clinical Oncology, 2009
- Prognostic Impact of Histological Subtype on Surgically Treated Localized Renal Cell CarcinomaJournal of Urology, 2009
- Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter ExperienceJournal of Clinical Oncology, 2005